pre-IPO PHARMA

COMPANY OVERVIEW

Medimetriks is a leading independent specialty pharmaceutical company dedicated to the Dermatology and Podiatry markets.


LOCATION

  • Fairfield, NJ, USA

  • THERAPEUTIC AREAS

  • Dermatology

  • WEBSITE

    https://www.medimetriks.com/


    CAREER WEBSITE

    https://www.medimetriks.com/careers


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Apr 27, 2020

    StayinFront Announces Multi-year Partnership Renewal with Medimetriks Pharmaceuticals


    Jun 18, 2019

    Medimetriks Pharmaceuticals Focuses on Advancing MM36 (difamilast) Through Phase 3 Trials; Extinguishes Debt Owed to Knight Therapeutics


    Dec 14, 2017

    Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi™ (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo


    Aug 31, 2016

    Medimetriks Pharmaceuticals' New Drug Application for Ozenoxacin Cream, 1% Accepted for Review by FDA


    Jun 27, 2016

    Medimetriks Pharmaceuticals, Inc. Submits a New Drug Application to FDA for Ozenoxacin Cream, 1%, a Novel Impetigo Treatment


    For More Press Releases


    Google Analytics Alternative